257. Hepatic glycogenosis Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 14 / Drugs : 27 - (DrugBank : 7) / Drug target genes : 3 - Drug target pathways : 8
Hepatic glycogenosis and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
| ID | Diseases (Sorted by drug repositionability) |
|---|---|
| 257 | Hepatic glycogenosis |
| 6 | Parkinson disease |
| 19 | Lysosomal storage disease |
| 46 | Malignant rheumatoid arthritis |
| 49 | Systemic lupus erythematosus |
| 66 | IgA nephropathy |
| 86 | Pulmonary arterial hypertension |
| 96 | Crohn disease |
| 222 | Primary nephrotic syndrome |
| 271 | Ankylosing spondylitis |
| 113 | Muscular dystrophy |
| 93 | Primary biliary cholangitis |
| 107 | Juvenile idiopathic arthritis |
| 97 | Ulcerative colitis |
| 224 | Purpura nephritis |
| 220 | Rapidly progressive glomerulonephritis |
| 30 | Distal myopathy |